The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Kata dasar adalah elemen fundamental dalam struktur bahasa Indonesia yang menjadi pondasi pembentukan berbagai jenis kata lainnya. Memahami konsep kata dasar sangat penting bagi siapa saja yang ingin ...

The top job in Pakistani higher education is, by design, a temporary one. The chairperson of the Higher Education Commission (HEC) now gets a mere two years — instead of four — to steward the ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Windows 11 is available for download worldwide. Microsoft has released it as a free upgrade, which means you do not need to pay to upgrade your computer to Windows 11. It is available for free ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

A meeting of the search committee regarding the appointment of a permanent Chairman of the Higher Education Commission (HEC) was held on Wednesday, while Education Secretary Nadeem Mahbub has assumed ...

The Higher Education Commission (HEC) of Pakistan has launched a major digital transformation initiative to improve public universities across the country. This project aims to replace old, ...

A local court in Islamabad ordered the reinstatement of Dr Ziaul Qayyum as Executive Director of the Higher Education Commission (HEC). However, despite the court's orders, the HEC administration did ...

ISLAMABAD – The court has reinstated Professor Dr. Zia-ul-Qayyum as the Executive Director of the Higher Education Commission (HEC) after suspending his termination orders issued earlier this year.

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.